a fixed-dose neuroleptic trial showed that thought disorder and auditory hallucinations respond rapidly to treatment with a da receptor blocker ( haloperidol ) , while no significant effect on other symptom cluster scores occurred during the initial 2 weeks of treatment .
C0040615
neuroleptic
C0018546
haloperidol